ACTA Will Hurt Access To Generics: Flynn Explains
1 CommentBy Ed Silverman // January 31st, 2012 // 8:14 am
• Pharma Blog » Archives
TRIPS
Essential Meds, Patents & NCDs: Abbott Explains
Make a commentBy Ed Silverman // September 23rd, 2011 // 9:38 am
A Whitewash? Trade Talks And Access To Meds
Make a commentBy Ed Silverman // September 13th, 2011 // 7:43 am
Novartis, A Gleevec Patent & India: Baker Explains
1 CommentBy Ed Silverman // September 7th, 2011 // 9:21 am
Novartis Patent Dispute In India Heats Up
2 CommentsBy Ed Silverman // September 6th, 2011 // 8:35 am
New Zealand Chafes Over Pharma And Trade Talks
2 CommentsBy Ed Silverman // June 20th, 2011 // 10:14 am
Novartis, Gleevec And A Patent Dispute In India
2 CommentsBy Ed Silverman // April 4th, 2011 // 9:10 am
Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // February 10th, 2011 // 8:09 am
New Zealand Challenges Pharma In Trade Talks
Make a commentBy Ed Silverman // December 8th, 2010 // 11:45 am
India, Free Trade And Access To Generic AIDS Meds
1 CommentBy Ed Silverman // September 17th, 2010 // 8:48 am